PE20030362A1 - Sistemas de indan-1-ol-sustituidos en c2 y procedimiento para su preparacion - Google Patents
Sistemas de indan-1-ol-sustituidos en c2 y procedimiento para su preparacionInfo
- Publication number
- PE20030362A1 PE20030362A1 PE2002000810A PE2002000810A PE20030362A1 PE 20030362 A1 PE20030362 A1 PE 20030362A1 PE 2002000810 A PE2002000810 A PE 2002000810A PE 2002000810 A PE2002000810 A PE 2002000810A PE 20030362 A1 PE20030362 A1 PE 20030362A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- cycloalkyl
- indan
- procedure
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 5-CHLORO-2-FLUORO-METHANOSULFONYL-INDAN-1-OL Chemical compound 0.000 abstract 1
- 239000002830 appetite depressant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/17—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A SISTEMAS DE INDAN-1OL-SUSTITUIDOS EN C2 DE FORMULA I DONDE: a) R1-R4 SON H, F, Cl, Br, I, CH, N3, NO, OALQUILO C1-8, O CICLOALQUILO C3-C8, O-CH2-FENILO, O-FENILO, ENTRE OTROS; X ES S, SO, SO2; Y ES (CH2)p DONDE p PUEDE SER 0-3; R5 ES CF3, ALQUILO C1-C18, CICLOALQUILO C3-C4, CICLOALQUILO C6-C8, DONDE LOS GRUPOS ALQUILO PUEDEN ESTAR REEMPLAZADOS CON F; R6 ES F. Cl, Br, CN, ALQUILO C1-C18, CICLOALQUILO C3-C8, ENTRE OTROS b) R1-R4 SON H, F, Cl, Br, I, CH, N3, NO2, OH, ENTRE OTROS, X ES S, SO, SO2, Y ES (CH2)p SIENDO p IGUAL A 0-3, R5 ES CF3, ALQUILO C1-C18, CICLOALQUILO C3-C4 Y C6-C8 , ENTRE OTROS; R6 ES F, Cl, Br, CN, ALQUILO C1-C18, ENTRE OTROS; R7 ES ALQUILO C1-C12, CICLOALQUILO C3-C8, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION. UN COMPUESTO PREFERIDO 5-CLORO-2-FLUORO-METANOSULFONIL-INDAN-1-OL . LOS COMPUESTOS MENCIONADOS SON UTILES COMO AGENTES ANOREXICOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10142663A DE10142663B4 (de) | 2001-08-31 | 2001-08-31 | C2-Disubstituierte Indan-1-ol-Systeme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030362A1 true PE20030362A1 (es) | 2003-06-02 |
Family
ID=7697234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000810A PE20030362A1 (es) | 2001-08-31 | 2002-08-23 | Sistemas de indan-1-ol-sustituidos en c2 y procedimiento para su preparacion |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6982353B2 (es) |
| EP (1) | EP1425264B1 (es) |
| JP (1) | JP4250078B2 (es) |
| AT (1) | ATE412630T1 (es) |
| AU (1) | AU2002336982B2 (es) |
| CA (1) | CA2458523A1 (es) |
| DE (2) | DE10142663B4 (es) |
| IL (1) | IL160603A0 (es) |
| MX (1) | MXPA04001849A (es) |
| PE (1) | PE20030362A1 (es) |
| WO (1) | WO2003020695A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| EP1849465A4 (en) * | 2005-02-18 | 2008-12-24 | Takeda Pharmaceutical | AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050564A (en) | 1958-12-02 | 1962-08-21 | Exxon Research Engineering Co | Preparation of new hydroperoxides by the cooxidation of olefinic compounds and mercaptans |
| US3016349A (en) | 1959-08-10 | 1962-01-09 | Exxon Research Engineering Co | Denitrogenation of petroleum |
| US3043824A (en) | 1959-09-28 | 1962-07-10 | Exxon Research Engineering Co | Hydroperoxide and sulfoxide compounds |
| US3016348A (en) | 1959-11-02 | 1962-01-09 | Universal Oil Prod Co | Manufacture and use of sulfided hydrocarbon purification catalyst |
| YU33726B (en) | 1969-07-04 | 1978-02-28 | Montedison Spa | Process for cross-linking of plastomers |
| EP0729465B1 (en) | 1993-11-19 | 2003-01-22 | PARKE, DAVIS & COMPANY | Pyrone derivatives as protease inhibitors and antiviral agents |
| US5808062A (en) | 1993-11-19 | 1998-09-15 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
| US5622514A (en) | 1995-06-30 | 1997-04-22 | The Whitaker Corporation | Coverless pin grid array socket |
| IL124756A0 (en) * | 1995-12-06 | 1999-01-26 | Venantius Limited | Indane dimer compounds and their pharmaceutical use |
| PT944648E (pt) | 1996-08-30 | 2007-06-26 | Novo Nordisk As | Derivados do glp-1. |
| US5985913A (en) | 1996-11-29 | 1999-11-16 | Osi Pharmaceuticals, Inc. | Tetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereof |
| IL127296A (en) | 1996-12-31 | 2003-01-12 | Reddy Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| AU8031698A (en) | 1997-06-05 | 1998-12-21 | Venantius Limited | Indane compounds and their pharmaceutical use |
| HUP0003999A3 (en) | 1997-07-16 | 2003-03-28 | Novo Nordisk As | Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them |
| DE19844547C2 (de) * | 1998-09-29 | 2002-11-07 | Aventis Pharma Gmbh | Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19908533A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
| EP1078632A1 (en) | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| DE10142660A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142662B4 (de) | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
| DE10142667B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
| DE10142661B4 (de) | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| DE10142659A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142666A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
-
2001
- 2001-08-31 DE DE10142663A patent/DE10142663B4/de not_active Expired - Fee Related
-
2002
- 2002-08-17 IL IL16060302A patent/IL160603A0/xx unknown
- 2002-08-17 DE DE50212971T patent/DE50212971D1/de not_active Expired - Lifetime
- 2002-08-17 JP JP2003524966A patent/JP4250078B2/ja not_active Expired - Fee Related
- 2002-08-17 AT AT02772163T patent/ATE412630T1/de not_active IP Right Cessation
- 2002-08-17 WO PCT/EP2002/009203 patent/WO2003020695A1/de active Application Filing
- 2002-08-17 CA CA002458523A patent/CA2458523A1/en not_active Abandoned
- 2002-08-17 EP EP02772163A patent/EP1425264B1/de not_active Expired - Lifetime
- 2002-08-17 MX MXPA04001849A patent/MXPA04001849A/es active IP Right Grant
- 2002-08-17 AU AU2002336982A patent/AU2002336982B2/en not_active Ceased
- 2002-08-23 PE PE2002000810A patent/PE20030362A1/es not_active Application Discontinuation
- 2002-08-29 US US10/231,418 patent/US6982353B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2458523A1 (en) | 2003-03-13 |
| US6982353B2 (en) | 2006-01-03 |
| US20030181491A1 (en) | 2003-09-25 |
| JP4250078B2 (ja) | 2009-04-08 |
| EP1425264B1 (de) | 2008-10-29 |
| DE10142663B4 (de) | 2004-08-19 |
| AU2002336982B2 (en) | 2008-01-31 |
| IL160603A0 (en) | 2004-07-25 |
| DE10142663A1 (de) | 2003-03-27 |
| JP2005501902A (ja) | 2005-01-20 |
| MXPA04001849A (es) | 2004-06-15 |
| DE50212971D1 (de) | 2008-12-11 |
| ATE412630T1 (de) | 2008-11-15 |
| EP1425264A1 (de) | 2004-06-09 |
| WO2003020695A1 (de) | 2003-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20021091A1 (es) | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion | |
| PE20011067A1 (es) | Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas | |
| DK0640592T3 (da) | N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister | |
| AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
| ES2036580T3 (es) | Composiciones quimicas y su uso como aditivos a combustibles. | |
| BR9806296B1 (pt) | compostos de ácido sulfìnico, mistura, composição e uso dos mesmos. | |
| ES2061463T3 (es) | Compuestos de piperidina y su preparacion y uso. | |
| DK287986A (da) | (meth)-acrylsyrederivater af tricyclodecaner, deres fremstilling og anvendelse som dentalmaterialer | |
| MX165512B (es) | Aditivo de carbamato para composicion lubricante | |
| ES2155825T3 (es) | Compuestos para inmunoensayos de polarizacion de fluorescencia, e inmunoensayos que utilizan los mismos. | |
| ES2099528T3 (es) | Utilizacion de polisiloxanos con modificacion organofuncional, para desespumar carburante diesel. | |
| PE29798A1 (es) | Acetidinas | |
| ES2066057T3 (es) | Compuestos de organosilano. | |
| ES2099013B1 (es) | Nuevos compuestos de polimetilpiperidina con grupos de silano y su uso como estabilizantes para materiales organicos. | |
| ES2045126T3 (es) | Agentes terapeuticos. | |
| ES2052515T3 (es) | Nuevos compuestos quirales de fosfinopirrolidina y su uso para sintesis asimetrica de compuestos opticamente activos. | |
| ES2064729T3 (es) | Complejos de rutenio (iii) como agentes antineoplasticos. | |
| PE20020599A1 (es) | Derivados de acido amino-furan-2-il-acetico sustituido o de acido amino-tien-2-il-acetico sustituido, procedimiento para su preparacion, medicamentos que los contienen, uso de estos compuestos para la preparacion de medicamentos para el tratamiento d | |
| PE20030363A1 (es) | Utilizacion de sistemas de indan-1-ol varias veces sustituidos, para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad | |
| PE20030362A1 (es) | Sistemas de indan-1-ol-sustituidos en c2 y procedimiento para su preparacion | |
| ATE375348T1 (de) | Analoge von n-acetylardeemin, verfahren zur herstellung und verwendung dieser analogen | |
| NO20022977D0 (no) | Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter | |
| ES2063879T3 (es) | Compuestos triacinicos. | |
| MX9700365A (es) | Uso de benzaldehidos para asignar hidrocarburos. | |
| PE36098A1 (es) | Nuevas heteroariloxazolidinonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |